Searched for
GILEAD SCIENCES
Emcure Pharmaceuticals partners with Gilead Sciences to produce HIV prevention drug LenacapavirEmcure Pharmaceuticals has partnered with Gilead Sciences Ireland UC to manufacture and distribute generic lenacapavir for HIV prevention a...03 Oct, 2024, 10.57 AM IST- Dr Reddy’s inks licensing pact with Gilead for Remdesivir to treat Covid-19The Hyderabad headquartered drug maker will obtain technology transfer from Gilead for manufacturing of the drug wherein the Indian firm wo...13 Jun, 2020, 04.38 PM IST
- More companies in talks for Remdesivir licenceThis week, Cipla, Jubilant Life Sciences, Hetero and Mylan signed non-exclusive licensing agreements for the antiviral drug which received ...15 May, 2020, 09.05 AM IST
- Gilead sign licensing deal for Remdesivir with three Indian companiesET had reported on May 5 that Gilead Sciences was in talks with several Indian companies including Jubilant Life Sciences for a licensing d...13 May, 2020, 08.27 AM IST
- NPPA seeks clarification on Gilead's drug pricing pleaNational Pharmaceutical Pricing Authority has sought clarifications from the company. Gilead had sought exemption from price control for it...31 Jan, 2020, 07.21 AM IST
- Natco gets DCGI nod to launch hepatitis C drug in IndiaNatco Pharma has received approval from the Drugs Controller General of India (DCGI) to launch generic version of hepatitis C treatment dru...15 Dec, 2015, 12.37 PM IST
- Natco settles patent suit with Gilead, others over TamifluNatco Pharma and its partner Alvogen today said they have settled patent infringement suit with Gilead Sciences Inc and others over Tamiflu.14 Dec, 2015, 11.37 AM IST
- Dr Reddy's to launch Hepatitis C drug in IndiaSofosbuvir is a medicine used for chronic Hepatitis C infection and sold globally by Gilead Sciences Inc, under its brand Sovaldi.23 Mar, 2015, 06.21 PM IST
- Zydus Cadila launches Gilead's Hepatitis C drug in IndiaSofosbuvir is a medicine used for chronic hepatitis C infection and sold globally by Gilead Sciences Inc, under its brand Sovaldi.17 Mar, 2015, 04.19 PM IST
- Strides Arcolab inks pact with Gilead Sciences for HIV drugStrides has entered into a licensing agreement with Gilead to manufacture and distribute latter's low-cost TAF used for HIV treatment in de...20 Jan, 2015, 01.03 PM IST
- CCI rules out case against Gilead SciencesCCI has rejected a complaint against Gilead Sciences Inc that alleged the US-based pharmaceutical company of abusing its dominant position.12 Mar, 2013, 02.46 PM IST
- Strides signs pact with Gilead Sciences to promote HIV drugStrides Arcolab said it has inked a pact with US-based Gilead Sciences to sell low-cost generic versions of latter's HIV medicine 'emtricit...07 Aug, 2012, 02.25 AM IST
- Strides Arcolab inks pact with Gilead Sciences to promote HIV drugStrides has inked a pact with Gilead Sciences Inc to sell low-cost generic versions of latter's HIV medicine 'emtricitabine' in developing ...06 Aug, 2012, 02.49 PM IST
- Gilead Sciences inks deals with 3 Indian companies including Ranbaxy Laboratories for low-cost HIV drugGilead Sciences has signed deals with 3 Indian firms to collaborate on promoting access to HIV medicine emtricitabine in developing nations.02 Aug, 2012, 09.22 PM IST
- US bio-pharma firm Gilead Sciences in pact with four Indian cosUS-based bio-pharmaceutical company Gilead Sciences on Tuesday entered into new licensing pacts with four Indian firms.12 Jul, 2011, 10.43 PM IST
- Ranbaxy inks pact with Gilead for three generic HIV/AIDS drugsRanbaxy has entered into an agreement with US-headquartered Gilead Sciences to manufacture and market three new generic HIV/AIDS drugs.12 Jul, 2011, 02.47 PM IST
- Cipla on firm ground in patent challengeIn what could strengthen Cipla's patent challenge against global major Gilead Science's patent application for its key HIV drug, Viread, th...26 Jan, 2008, 12.36 AM IST
Load More
